Ablevia Biotech Gmbh
We develop injectable decoy biotherapeutics for the selective and quick removal of harmful circulating antibodies from blood. Our peptide-based decoys can be specifically adapted for vector-neutralizing antibodies in gene therapy, or drug-neutralizing anti-drug antibodies in enzyme- and factor replacement therapies (e.g. glycogen storage diseases, hemophilia & other rare conditions).
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Ablevia Biotech Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- GS
Gerhard Stadlmayr
Senior Scientist · Science
EmailPhone - KF
Katrin Fischer
Scientist · Research & Development
EmailPhone - KY
Kristyna Yatsyk
Wissenschaftlich-technische Assistentin · Other
EmailPhone - MK
Melanie Kogler
Staff Scientist · Science
EmailPhone - CP
Christof Paparella
Co-founder · General Business & Management
EmailPhone
Showing 5 of 7 verified contacts
Top roles at Ablevia Biotech Gmbh
6 distinct titles indexed · top 6 shown.
- 2scientist
- 1co-founder
- 1research technician
- 1senior scientist
- 1staff scientist
- 1wissenschaftlich-technische assistentin
Sign up to unlock all 7 contacts at Ablevia Biotech Gmbh
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Ablevia Biotech Gmbh
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.